Related Experiment Video
Updated: Jun 27, 2026
08:59
Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
Paraoxonase 1 (PON1) status and substrate hydrolysis
Rebecca J Richter1, Gail P Jarvik, Clement E Furlong
1Department of Medicine-Division of Medical Genetics, Box 357720, University of Washington, Seattle, WA 98195-7720, USA.
Toxicology and Applied Pharmacology
|December 17, 2008
Summary
Paraoxonase 1 (PON1) enzyme activity and its Q192R genetic variants influence protection against organophosphorus (OP) compounds. This study converts PON1 status data into physiologically relevant detoxification rates for specific OP exposures.
Area of Science:
- Biochemistry
- Toxicology
- Pharmacogenetics
Background:
- Paraoxonase 1 (PON1) is crucial for detoxifying organophosphorus (OP) compounds.
- The PON1 Q192R polymorphism impacts hydrolysis rates and in vivo protection against OP agents.
- Existing assays optimize phenotype separation but not in vivo detoxification rate assessment.
Purpose of the Study:
- To adapt a non-OP substrate assay for determining PON1 status.
- To convert PON1 status data into physiologically relevant in vivo detoxification rates for diazoxon (DZO) and chlorpyrifos oxon (CPO).
- To generate conversion factors for assessing hydrolysis rates of different substrates.
Main Methods:
- Utilized a two-substrate enzyme assay to determine PON1 plasma levels and Q192R phenotypes (QQ, QR, RR).
- Adapted the assay to convert PON1 status data into detoxification rates.
- Generated specific conversion factors for DZO and CPO hydrolysis.
Main Results:
- The Q192R polymorphism differentially affects hydrolysis efficiency for various OP compounds.
- PON1(R192) shows higher efficiency for chlorpyrifos oxon (CPO) hydrolysis compared to PON1(Q192).
- Both PON1 level and Q192R allotype are critical for protection against certain OP exposures, while others depend primarily on PON1 levels.
Conclusions:
- Plasma PON1 levels are always important for OP detoxification.
- The Q192R polymorphism significantly influences protection against specific OP exposures like CPO.
- The developed method allows for the conversion of PON1 status to physiologically relevant detoxification rates, aiding in risk assessment.
Related Concept Videos
01:19Enzyme Kinetics
Enzymes speed up reactions by lowering the activation energy of the reactants. The speed at which the enzyme turns reactants into products is called the rate of reaction. Several factors impact the rate of reaction, including the number of available reactants. Enzyme kinetics is the study of how an enzyme changes the rate of a reaction.
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
01:24Peroxisomes
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
02:54Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:08Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
01:30Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.